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KAY (1957) reported in this journal a study, using the mixed cell agglutination
technique, of bladder tumour cells. His results showed a rough correlation
between the strength of agglutination and the degree of malignancy as judged
histologically, and he found a general pattern of weaker agglutination associated
with greater malignancy. This was not constant, however, since one well differen-
tiated tumour was totally unagglutinable, while two anaplastic pleomorphic
growths gave normal, strong agglutination. The present study, suggested by
Kay's work, reports the findings, using mixed cell agglutination, on thirty-two
malignant tumours of the human stomach and large bowel.
METHODS
Specimens ofgastric and colonic carcinomata were obtained from the operating
theatre within fifteen minutes of resection. The viscus was opened, mucus and
faeces gently washed away with tap water and the lesion examined. Two samples
of tissue were then taken in each case. A small piece of the surface of the
growth was removed with a sharp knife, and a piece of unaffected mucosa from
an adjacent part of the organ was also taken. Both specimens were stored
separately at -20° C. in 20 per cent glycerol in saline. The organ was then
placed in formol saline for routine histological study. As soon as convenient,
but usually within a few days, a mucosal cell suspension of both malignant
and normal tissue was made, using a solution of oxidised ascorbic acid
(Cowan, 1962). The suspensions were stored, like the tissues, in 20 per
cent glycerol in saline at -200 C. A scraping of buccal cells from each patient
was obtained in the post-operative period; these cells were stored in suspension
in the same manner as the gastrointestinal cells and mixed cell agglutination
performed on them served as a control of technique. Finally, a specimen of
saliva, and often gastric juice in addition, was secured from each patient and the
secretor status determined bythe methodofantibody-inhibition (Race and Sanger,
1958).
Mixed cell agglutination was performed after the manner described by Coombs,
Bedford and Rouillard (1956). Experience showed that with gastrointestinal
cells, stronger mixed cell agglutination followed if the period of incubation with
antibody was extended to two hours or more. With group 0 tissues, an extract
of Ulex europaeus L. was used as anti H to detect H substance in the tissues.
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Controls.-For group A and B tissues, three tubes were put up; e.g.-
Tissue Antiserum RBC's
Mucosal cell group A . Anti A . A (test)
Mucosal cell group A . Anti A . 0 (control)
Mucosal cell group 0 . Anti A . A (control)
For group 0 tissues, two tubes were put up-
Tissue Antiserum RBC's
Mucosal cell group 0 . Ulex . 0 (test)
Mucosal cell group 0 . Anti A . A (control)
The strength of mixed cell agglutination was measured by counting the tissue
cells and noting the percentage which showed agglutination. It was found, in
general, that mixed cell agglutination wasmuchless strong in colon specimensthan
stomach, amounting to only one-third of the cells in some instances. Weak
results, as judged by the lesser number of cells which showed agglutination at all,
were accompanied in general by a diminished number ofred cells adherent to the
individual tissue cells.
RESULTS
Thirty-two tumours, all carcinomata, were studied. Their origins were
Stomach . . . . 9
Caecum . . . . 4
Ascending colon . . . 1
Transverse colon . . 1
Splenic flexure . . . 1
Descending colon . . 3
Pelvic colon . . . 8
Pelvi-rectal junction . . 1
Rectum . . . . 4
32
The results are represented in Table I.
DISCUSSION
It is possible that the weaker agglutination in colonic specimens was due to
bacterial contamination of the tissue cells, in spite of the bacteriocidal action of
the oxidized ascorbic acid solution used to disperse the cells and in spite of the
comparative expediency with which tissue was obtained once it had been removed
from the patient. Broberger and Perlman (1959) were very conscious of this
effect of bacterical contamination, and in obtaining specimens of human colon
for the preparation of antigen, selected colons of newborn infants who had died
soon after birth and before they had been fed. On the other hand, this poor
agglutination may well reflect diminished antigen content ofthe cells. Hartmann
(1941) found that the blood group antigen content of the gastrointestinal tract
epithelium diminished gradually from the stomach towards the rectum both in
secretors and non-secretors, and in two specimens of colon resected for carcinoma
from group Apatients ofundetermined secretor status, Glynn andHolborow (1959)
were able to obtain only traces of staining in the mucosa. Moreover, Szulman
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TABLE I.-Mixed Cell Agglutination Experiment8; Mucosal Celt/Erythrocyte,
Malignant Cell/Erythrocyte and Buccal Cell/Erythrocyte
Site of
No. tumour
S1 . Stomach
S2 . Stomach
S3 . Stomach
S4 . Stomach
S5 . Stomach
S6 . Stomach
S7 . Stomach
S8 Stomach
59 . Stomach
C1 Transverse colon
C2 Pelvic colon
C3 . Pelvic colon
C4 Pelvic colon
C6 . Pelvic colon
C6 Rectum
C7 . Rectum
C8 . Pelvi-rectal junction
C9 . Pelvic colon
CIO . Pelvic colon
Cll . Caecum
C12 . Pelvic colon
C13 . Descending colon
C14 . Pelvic colon
C15 . Rectum
C16 . Rectum
C17 . Caecum
C18 . Ascending colon
C19 . Splenic flexure
C20 . Descending colon
C21 . Caecum
C22 . Descending colon
C23 . Caecum
Percentage of cells
showing MCA
Blood Secretor -A
group status Normal Tumour
A
0
0
A
0
B
0
0
A
A
0
A
B
A
0
A
0
0
0
0
A
A
0
0
A
A
A
A
B
0
B
0
S
NS
S
S
NS
S
S
NS
S
S
S
S
S
S
S
NS
NS
S
S
S
S
S
S
S
S
S
S
S
S
NS
S
NS
90
60
80
95
NEG
100
52
NEG
5
51
10
96
21
80
36
41
NEG
5
NEG
94
21
42
52
26
52
56
55
36
16
NEG
16
NEG
50
20
60
95
NEG
76
50
NEG
6
16
11
71
42
45
30
18
NEG
36
NEG
13
NEG
32
27
25
16
58
28
11
90
NEG
33
NEG
N.B.-Agglutination less than 10 per cent scored as negative.
Difference of less than 5 per cent scored as equal degrees of agglutination.
Abbreviations: MCA Mixed cell agglutination
S Secretor
NS Non-secretor
POS Positive
pos Positive, weak
NEG Negative
These results may be summarizec as follows:
TABLE II.-Thirty-two Tumours and Adjacent Unaffected Tissue
Greater agglutination in unaffected tissue . . 16
Greater agglutination in tumour tissue . . . 4
Equal degrees of agglutination in both specimens . 5
Negative agglutination in both specimens . . 7
(1960), who like Glynn and Holborow used the fluorescent antibody technique,
could not demonstrate any antibody at all in the "distal colon", even in secretors.
Normal ti88ue.-It will be noted that in eight instances negative agglutination
was obtained. Seven of these results were from group 0 subjects, of whom five
were non-secretors, but using this technique, it has been possible in nearly every
MCA
buccal
cells
POS
POS
POS
POS
NEG
POS
POS
NEG
pos
POS
POS
POS
POS
POS
POS
POS
NEG
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
POS
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case to demonstrate blood group antigen in the mucosal cells of the stomach and
colon of group A and B subjects.
Tumourtissue.-Table II suggests that ofthe tumours wherepositive agglutina-
tion has been obtained, well over half contained less blood group antigen than the
adjacent normal tissue. These results are interesting in the light of the work
which has demonstrated without doubt a loss of tissue specific antigen by malig-
nant cells (Weiler, 1956; Nairn et al., 1960), but it would be unwise to compare too
closely loss of tissue specific antigen and loss of blood group antigen. This
group of cases is, however, in general agreement with the findings of Kay (1957)
on bladder tumour cells, although the present work failed to demonstrate any
correlation between impairmant of agglutination and degree of malignancy.
Thus, of the tumours studied, one was well differentiated and four showed poor
differentiation with little attempt at acinar formation, but the majority were
moderately well differentiated adenocardinomata; within this intermediate
group all degree of discrepancy were found between the agglutinations of tumour
and normal tissue.
The results also differ from Kay's in one other respect. Kay was able to
examine normal tissue in only six patients, but he never found the agglutination
in the tumour tissue to be stronger, rather than weaker, than normal; andindeed,
inasmuch as he always found the normal tissue to give strong agglutination,
this could not have been apparent in any case.
In the present study, stronger agglutination than normal was shown in four of
thirty-two tumours, a finding which represents an apparent antigen gain in these
cases. The greater degree of agglutination was not due to the tumours being
mucus-secreting and therefore containing excessive blood-group substance; only
one of the four tumours on serial sectioning was mucus-secreting in type, and one
of the tumours showing weaker agglutination than normal presented a similar
histological picture.
Both Weiler (1959) and Green (1959) in their studies ofantigen loss in carcino-
genesis felt that there might, on occasions, be some antigen gain by tumour
cells, but they concluded that such gains were not organ specific. Again, Nairn,
Richmond and Fothergill (1960), using the fluorescent antibody technique to
stain normal and malignant cells with non-immune rabbit globulin, reported that
in some carcinomata (although never in the colon), brighter staining was obtained
with tumour tissue. On the more relevant plane of blood group antigens, Zacho
(1932) was able to demonstrate MN antigens in malignant tumours, but never in
benign.
Ofthe four instances in the present work where stronger agglutination occurred
with tumour tissue (No. C4, C9, C20, C22), all were tumours ofthe colon and three
of the four were from group B patients, indeed the only group B colonic tissues
examined. Springer et al. (1956) havedemonstratedinE. coli 086 apolysaccharide
having powerful group B activity, and it is possible that malignant cells are able
to take up from the bowel bacterial exotoxins containing such antigen to a greater
degree than normal cells. The taking up of such toxins has been put forward
as an explanation of the occasional acquisition of group B antigen by red cells
(Stratton and Renton, 1959), although later work demonstrating the presence of
A antigen as well as B in this strain of E. colti (Gonano, Modiano and Andreis,
1961; Pettenkofer, Maassen and Bickerich, 1960) poses a further complication.
It is of interest, however, that in four communications reporting the acquisition
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of blood group B antigen by red cells (Cameron et al., 1959; Giles et al., 1959;
Marsh, Jenkins and Walther, 1959; Stratton and Renton, 1959), a total oftwelve
patients are described of whom eight had carcinoma of the colon or rectum.
It might be supposed that even if a malignant cell has lost its own intrinsic
antigen, it might, in secretors, adsorb antigen from the lumen ofthe gut, although
this consideration might not operate so forcibly in the colon where the antigen
level ofthe bowel contents is not so great (Witebsky and Neter, 1935). Ifmalig-
nant cells do, in fact, lose intrinsic antigen, then this point could explain why this
is often not apparent, but if, in secretors, one still discovers loss of antigen, then
the finding is the more significant.
Kay (1957), in assessing hisresults, draws attention to features ofthe malignant
cell such as decreased adherence, irregularity ofthe surface and increased negative
charge which could militate against strong mixed cell agglutination, and he feels
that the results should perhaps be interpreted in the light of these factors rather
thanpostulating agraded loss ofblood group antigen. Such considerations cannot
be applied, however, to those instances in the present study ofincreased agglutina-
tion on tumour cells, and the final impression is that while physical alteration
of the surface of the malignant cell may well complicate the issue, malignant
change in gastointestinal cells can often be attended by some alteration of the
blood group antigen content.
SUMMARY
Thirty-two malignant tumours of the human gastrointestinal tract have been
examined for blood group antigen by mixed cell agglutination and the results
compared with adjacent normal tissue. The buccal cells ofthe patients have also
been examined by mixed cell agglutination and the secretor status of the
individuals determined.
In sixteen ofthe tumours examined, agglutination was not as strong as in the
normal tissue and in four tumours the degree of agglutination was greater than
normal.
This work was part of a project the results of which were submitted as a
thesis for the degree ofM.D. ofthe University ofLiverpool. I am deeply grateful
to Dr. R. R. A. Coombs for much help and at whose suggestion the work was done.
Mr. W. T. A. Donohoe of the Department of Medicine, University of Liverpool,
was responsible for the skilful serological testing of the specimens of saliva and
gastric juice.
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